Table 1 The demographic and characteristics of the 27 included patients.
From: Pelvic MRI and CT images are interchangeable for measuring peripouch fat
Parameters | Values | Parameters | Values | ||
|---|---|---|---|---|---|
Age at IBD diagnosis (y) | 21(14–35) | Preoperative biologics | No | 14(51.9%) | |
Age at pouch construction (y) | 36(26–47) | Yes | 13(48.1%) | ||
Time from diagnosis to pouch construction (y) | 9 (4–20) | Postoperative immunomodulator | No | 25(92.6%) | |
Pouch survival (m) | 48 (24–96) | Yes | 2(7.4%) | ||
Time from CT imaging to MRI imaging (d) | 20(−90–70) | Postoperative biologics | No | 24(88.9%) | |
Pouch failure | No | 13(48.1%) | Yes | 3(11.1%) | |
Yes | 14(51.9%) | Extensive colitis | No | 0(0%) | |
Final diagnosis | Normal pouch | 3(11.1%) | Yes | 27(100%) | |
IPS | 5(18.5%) | Toxic megacolon | No | 26(96.3%) | |
Acute pouchitis | 1(3.7%) | Yes | 1(3.7%) | ||
Refractory pouchitis | 4(14.8%) | Pouch type | J pouch | 26(96.3%) | |
Cuffits | 5(18.5%) | others | 1(3.7%) | ||
Surgical complication | 8(29.6%) | Stage of pouch surgery | 2 | 13(48.1%) | |
Anismus | 1(3.7%) | 3 | 8(29.6%) | ||
Anastomosis | Handsewn | 4(14.8%) | redo pouch | 6(22.2%) | |
Stapled | 15(55.6%) | EIM | No | 16(59.3%) | |
Unknown | 8(29.6%) | Yes | 11(40.7%) | ||
Gender | Female | 14(51.9%) | Autoimmune disease | No | 25(92.6%) |
Male | 13(48.1%) | Yes | 2(7.4%) | ||
Race | Caucasian | 23(85.2%) | PSC | No | 26(96.3%) |
Others | 4(14.8%) | Yes | 1(3.7%) | ||
Smoking | No | 21(77.8%) | Refractory pouchitis | No | 23(85.2%) |
Ex or active | 6(22.2%) | Yes | 4(14.8%) | ||
Chronic NSAID | No | 25(92.6%) | Cuffitis | No | 22(81.5%) |
use history | Yes | 2(7.4%) | Yes | 5(18.5%) | |
Indication of colectomy | Refractory colitis | 24(88.9%) | Pouch complication | No | 3(11.1%) |
Dysplasia | 3(11.1%) | Yes | 24(88.9%) | ||
Preoperative diagnosis | UC | 25(92.6%) | CD of pouch | No | 26(96.3%) |
IC or CD | 2(7.4%) | Yes | 1(3.7%) | ||
